Market Tracker

09/22 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

1.16
Delayed Data
As of Sep 22
 0.00 / 0.00%
Today’s Change
0.73
Today|||52-Week Range
2.47
-7.94%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.16
Today’s open1.17
Day’s range1.15 - 1.18
Volume2,840,338
Average volume (3 months)6,035,870
Market cap$341.3M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.01-0.42%
AGENAgenus Inc0.000.00%
CRISCuris Inc-0.02-1.26%
EDGEEdge Therapeutics In...+0.02+0.21%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts